Irritable Bowel Syndrome

ANMS Irritable Bowel Syndrome

Issue link: https://eguideline.guidelinecentral.com/i/70970

Contents of this Issue

Navigation

Page 10 of 11

Table 9. IBS Treatment Options for Global Symptoms and/or Overall Well-being Treatment Cognitive behavioral therapy Dynamic psychotherapy Hypnotherapy Key Points Psychological and behavioral therapy (1B) • Modifies maladaptive behaviors and thoughts • Improves global IBS symptoms • Improves global IBS symptoms • Improves global IBS symptoms Complementary alternative medicine Acupuncture Chinese herbal therapy • Improvement in IBS symptoms has not been shown in controlled trials • Data on efficacy in IBS is limited Table 10. Treatment Options for IBS-D Drug (Brand) Dose Antidiarrheals Loperamide (eg, Imodium® ) 5-HT3 ) Diphenoxylate (eg, Lomotil® antagonist Alosetron (Lotronex® ) 0.5-1.0 mg bid (2A-female, 2B-male) • Efficacious for IBS-D • FDA approved only through a risk management program for women with severe IBS-D who have not responded to conventional therapies • Concerns of serious complications of constipation and ischemic colitis (2A) Tricyclic antidepressants (See Table 7) Gut-selective antibiotic Rifaximin (Xifaxan® ) 400-550 mg tid (1B) • Global efficacy demonstrated in nonconstipating IBS • Improvement in bloating also demonstrated 2 mg daily to 4 mg qid prn; also available as liquid (2C) 5 mg ≤ qid (with atropine) Key Points • Useful for the treatment of diarrhea but no global symptom relief shown • Titrate dose to desired effect and avoid constipation

Articles in this issue

view archives of Irritable Bowel Syndrome - ANMS Irritable Bowel Syndrome